The UK government pledged in May to use artificial intelligence (AI) to prevent more than 20,000 cancer-related deaths a year by 2033, with the prime minister’s plans being welcomed by heal
A number of trends including tougher regulatory controls, increased transparency expectations, an increasingly vocal patient and greater requirements for post-marketing evidence have driven the gro
The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?